Guanidine-modified Nanoparticles As Robust BTZ Delivery Carriers and Activators of Immune Responses

Xiaodan Xu,Rui Wang,Dongdong Li,Jiajia Xiang,Wei Zhang,Xueying Shi,Hongxia Xu,Shasha Yao,Jiwei Liu,Shiqun Shao,Zhuxian Zhou,Feihe Huang,Youqing Shen,Jianbin Tang
DOI: https://doi.org/10.1016/j.jconrel.2023.04.004
IF: 11.467
2023-01-01
Journal of Controlled Release
Abstract:Dendritic cells (DCs), the primary antigen-presenting cells in the immune system, play a critical role in regulating tumor immune responses. However, the tumor immunosuppressive microenvironment severely impedes the process of antigen-presenting and DC maturation, thereby limiting the efficacy of cancer immunotherapy. In this work, a pH-responsive polymer nanocarrier (PAG) modified with aminoguanidine (AG) was constructed for the efficient delivery of bortezomib (BTZ) through bidentate hydrogen bonds and electrostatic adsorption formed between guanidine groups of PAG and boronic acid groups of BTZ. The obtained PAG/BTZ nanoparticles exhibited pH-responsive release of BTZ and AG in the acidic tumor microenvironment. On the one hand, BTZ induced potent immune activation by eliciting immunogenic cell death (ICD) and releasing damage-associated molecular patterns. On the other hand, the cationic AG significantly promoted antigen uptake by DCs and activated DC maturation. As a result, PAG/BTZ significantly stimulated tumoral infiltration of cytotoxic T lymphocytes (CTLs) and triggered robust antitumor immune responses. Thus, it showed potent antitumor efficacy when synergizing with an immune checkpoint-blocking antibody.
What problem does this paper attempt to address?